Cargando…
Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre
Objective: To report the current clinical features, treatment patterns and outcomes of female patients who were seen at a tertiary referral centre with a primary diagnosis of nocturia, and to assess the predictive factors of therapeutic management failure. Patients and methods: A retrospective chart...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583713/ https://www.ncbi.nlm.nih.gov/pubmed/31258948 http://dx.doi.org/10.1080/2090598X.2019.1589792 |
_version_ | 1783428442462617600 |
---|---|
author | Drangsholt, Siri Peyronnet, Benoit Arcila-Ruiz, Maria Sussman, Rachael D. Palmerola, Ricardo Pape, Dominique R. Rosenblum, Nirit Nitti, Victor W. Brucker, Benjamin M. |
author_facet | Drangsholt, Siri Peyronnet, Benoit Arcila-Ruiz, Maria Sussman, Rachael D. Palmerola, Ricardo Pape, Dominique R. Rosenblum, Nirit Nitti, Victor W. Brucker, Benjamin M. |
author_sort | Drangsholt, Siri |
collection | PubMed |
description | Objective: To report the current clinical features, treatment patterns and outcomes of female patients who were seen at a tertiary referral centre with a primary diagnosis of nocturia, and to assess the predictive factors of therapeutic management failure. Patients and methods: A retrospective chart review of all new female patients seen in a single-centre functional urology practice with the diagnosis of nocturia was performed. Up to three visits within a 12-month period from the time of presenting were reviewed. The primary endpoint was patient-reported improvement assessed at each follow-up visit and the change in the number of nocturia episodes. Results: In all, 239 female patients were included for analysis. The prevalence of nocturnal polyuria, reduced bladder capacity, and global polyuria were 75%, 40.2%, and 18.1%, respectively. Within the first two visits, 72.7% of patients had started a treatment beyond behavioural therapies. Anticholinergics were the most commonly initiated treatment (47.2% of patients). At the latest considered visit, 80 patients reported improvement in nocturia (45.5%) and there was a mean – 0.8 decrease in the number of nocturia episodes from 4 to 3.2, which was statistically significant (P < 0.001). There was no statistically significant association between any of the bladder diary findings and treatment outcomes. A smaller number of nocturia episodes was the only predictive factor of therapeutic management failure in multivariate analysis (odds ratio 0.10; P = 0.01). Conclusions: Whilst the prevalence of nocturnal polyuria in women with nocturia is high, the therapeutic management until 2016 seemed to rely mostly upon overactive bladder medications with a relatively low success rate. Abbreviations: BD: bladder diary; BPS: bladder pain syndrome; ICD(−9)-(10): International Classifications of Disease (ninth revision) (10th revision); NPI: Nocturnal Polyuria Index; OAB: overactive bladder; OR: odd ratio; POP: pelvic organ prolapse |
format | Online Article Text |
id | pubmed-6583713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-65837132019-06-28 Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre Drangsholt, Siri Peyronnet, Benoit Arcila-Ruiz, Maria Sussman, Rachael D. Palmerola, Ricardo Pape, Dominique R. Rosenblum, Nirit Nitti, Victor W. Brucker, Benjamin M. Arab J Urol Lower Urinary Tract Dysfunction: Original Article Objective: To report the current clinical features, treatment patterns and outcomes of female patients who were seen at a tertiary referral centre with a primary diagnosis of nocturia, and to assess the predictive factors of therapeutic management failure. Patients and methods: A retrospective chart review of all new female patients seen in a single-centre functional urology practice with the diagnosis of nocturia was performed. Up to three visits within a 12-month period from the time of presenting were reviewed. The primary endpoint was patient-reported improvement assessed at each follow-up visit and the change in the number of nocturia episodes. Results: In all, 239 female patients were included for analysis. The prevalence of nocturnal polyuria, reduced bladder capacity, and global polyuria were 75%, 40.2%, and 18.1%, respectively. Within the first two visits, 72.7% of patients had started a treatment beyond behavioural therapies. Anticholinergics were the most commonly initiated treatment (47.2% of patients). At the latest considered visit, 80 patients reported improvement in nocturia (45.5%) and there was a mean – 0.8 decrease in the number of nocturia episodes from 4 to 3.2, which was statistically significant (P < 0.001). There was no statistically significant association between any of the bladder diary findings and treatment outcomes. A smaller number of nocturia episodes was the only predictive factor of therapeutic management failure in multivariate analysis (odds ratio 0.10; P = 0.01). Conclusions: Whilst the prevalence of nocturnal polyuria in women with nocturia is high, the therapeutic management until 2016 seemed to rely mostly upon overactive bladder medications with a relatively low success rate. Abbreviations: BD: bladder diary; BPS: bladder pain syndrome; ICD(−9)-(10): International Classifications of Disease (ninth revision) (10th revision); NPI: Nocturnal Polyuria Index; OAB: overactive bladder; OR: odd ratio; POP: pelvic organ prolapse Taylor & Francis 2019-04-18 /pmc/articles/PMC6583713/ /pubmed/31258948 http://dx.doi.org/10.1080/2090598X.2019.1589792 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Lower Urinary Tract Dysfunction: Original Article Drangsholt, Siri Peyronnet, Benoit Arcila-Ruiz, Maria Sussman, Rachael D. Palmerola, Ricardo Pape, Dominique R. Rosenblum, Nirit Nitti, Victor W. Brucker, Benjamin M. Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre |
title | Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre |
title_full | Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre |
title_fullStr | Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre |
title_full_unstemmed | Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre |
title_short | Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre |
title_sort | nocturia in female patients: current clinical features, treatment patterns and outcomes at a tertiary referral centre |
topic | Lower Urinary Tract Dysfunction: Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583713/ https://www.ncbi.nlm.nih.gov/pubmed/31258948 http://dx.doi.org/10.1080/2090598X.2019.1589792 |
work_keys_str_mv | AT drangsholtsiri nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT peyronnetbenoit nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT arcilaruizmaria nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT sussmanrachaeld nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT palmerolaricardo nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT papedominiquer nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT rosenblumnirit nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT nittivictorw nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre AT bruckerbenjaminm nocturiainfemalepatientscurrentclinicalfeaturestreatmentpatternsandoutcomesatatertiaryreferralcentre |